
Simon Xi, Ph.D.
Co-Founder and Chief Executive Officer
Simon has 20 years of drug discovery experience in top pharmaceutical companies and academic institutes. Simon helped conceptualize the initial scientific strategy for Rgenta and has led the development of the discovery platform since its launch. Prior to Rgenta, Simon was the head of genomics and computational biology group at Abbvie Foundational Neuroscience Center where he established the genomics platform and computational biology function for target discovery and validation. Before Rgenta, Simon was an accomplished scientist and group leader at Pfizer, where he led multiple novel therapeutic targets into Pfizer’s discovery portfolio and established close collaborations with academic institutions. Simon has co-authored more than 30 research publications and is currently an adjunct faculty at Brandeis University and a principal investigator in the GTEx Consortium